Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

MMP9 enzyme could suppress tumors in colitis associated cancer, new study finds

An enzyme that plays an active role in inflammation could be a natural way to suppress tumors and ulcers in the colon that are found in colitis associated cancer (CAC), a type of colorectal cancer that is driven by chronic inflammation, according to a new study.

3 Jan 2017

DaVita releases recap of 2016 accomplishments

DaVita Inc., a leading independent medical group and a leading provider of kidney care services in the United States, today released a recap of major accomplishments for the company in 2016, marking its 16th year bringing quality of life to patients and teammates around the world.

30 Dec 2016

Clinical Genomics introduces new blood-based test for CRC recurrence monitoring

Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the launch of Colvera, a blood-based test for colorectal cancer (CRC) recurrence monitoring. Colvera is the result of a decade of research, development and clinical validation in more than 4,000 patients.

22 Dec 2016

Special Issue on digestive cancers offers five articles from experts in Latin America

ecancermedicalscience has published a new Special Issue on digestive cancers in Latin America, bringing together five articles from experts in the region.

21 Dec 2016

Regular use of aspirin could cut pancreatic cancer risk in half

Regular use of aspirin by people living in Shanghai, China, was associated with decreased risk for developing pancreatic cancer, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

20 Dec 2016

Novel genomics model allows personalized approach to radiation therapy

Cancer therapeutics is currently in the era of precision medicine - personalized medicine for individual patients based on their tumor biology.

20 Dec 2016

New SWOG review shows vitamin E and selenium do not prevent colorectal adenomas

Eight years ago, results from a landmark cancer prevention trial run by SWOG showed that a daily dose of vitamin E and selenium did not prevent prostate cancer.

20 Dec 2016

Regular NSAID use linked to increased risk of endometrial cancer mortality

Regular use of over-the-counter non-steroidal inflammatory drugs such as aspirin and ibuprofen is associated with an increased risk of dying in patients diagnosed with Type 1 endometrial cancers, according to a new population-based study led by The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

20 Dec 2016

HCI receives $8.8 million NIH grant to lead colon cancer study

Huntsman Cancer Institute at the University of Utah will head an international study to find out how lifestyle and other health factors impact colon and rectal cancer outcomes.

19 Dec 2016

Common heartburn medications could decrease effects of chemotherapy in cancer patients

Something as seemingly harmless as a heartburn pill could lead cancer patients to take a turn for the worse.

16 Dec 2016

New review shows how automated telephone systems could play vital role in delivery of health care

A new Cochrane Review, summarizing data from 132 trials of automated telephone systems in preventing and managing long-term health conditions, concludes that they probably have the potential to play an important role in the delivery of health care.

15 Dec 2016

Review highlights link between intestinal microbiota and colorectal cancer development

Recent evidence from animal models suggests a role for specific types of intestinal bacteria in the development of colorectal cancer (CRC).

9 Dec 2016

Oral cavity bacterium linked to development and progression of esophageal cancer

A type of bacterium usually found in the human mouth, Fusobacterium nucleatum, has been found to be related to the prognosis of esophageal cancer in Japanese patients by researchers from Kumamoto University, Japan.

9 Dec 2016

Four weeks of prehabilitation may help cancer patients to get in shape for surgery, study suggests

Just four weeks of prehabilitation may be enough to help some cancer patients get in shape for surgery.

2 Dec 2016

Researchers identify metabolite that promotes epithelial-mesenchymal transition of colorectal cancer cells

Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.

1 Dec 2016

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

MMP9 enzyme could suppress tumors in colitis associated cancer, new study finds

DaVita releases recap of 2016 accomplishments

Clinical Genomics introduces new blood-based test for CRC recurrence monitoring

Special Issue on digestive cancers offers five articles from experts in Latin America

Regular use of aspirin could cut pancreatic cancer risk in half

Novel genomics model allows personalized approach to radiation therapy

New SWOG review shows vitamin E and selenium do not prevent colorectal adenomas

Regular NSAID use linked to increased risk of endometrial cancer mortality

HCI receives $8.8 million NIH grant to lead colon cancer study

Common heartburn medications could decrease effects of chemotherapy in cancer patients

New review shows how automated telephone systems could play vital role in delivery of health care

Review highlights link between intestinal microbiota and colorectal cancer development

Oral cavity bacterium linked to development and progression of esophageal cancer

Four weeks of prehabilitation may help cancer patients to get in shape for surgery, study suggests

Researchers identify metabolite that promotes epithelial-mesenchymal transition of colorectal cancer cells

IQWiG finds colorectal cancer drug combination has added benefit only for some patients

Nature article highlights use of QGel's designer matrices for intestinal and colorectal cancer organoid culture

New public-private partnership launches major health effort to reduce cancer in San Francisco

Intestinal parasite increases susceptibility to colitis, study finds

Scientists find new way to bypass bowel cancer's defence against treatment

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in